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Department, G. Gennimatas Hospital, Thessaloniki, GreeceErgotism is a rare cause of vasospasm which occurs in 0.001–0.002% of patients receiving ergot derivatives primarily for
treatment of migraine [Dagher FJ, Sidawy AN. Ergotism, current treatment in vascular surgery. 4th ed. Ernst-Stanley.
p. 154–157]. Vasospasm though diffuse affects usually the lower limbs.
We present the case of a 38 year old woman with truly diffuse vasospasm, due to Cafergot suppositories abuse, of all four
extremities causing severe ischaemia to her left arm and bilateral intermittent calf claudication.
The patient was treated successfully and recovered from vasospasm 72 h later.Keywords: Ergotism; Vasospasm; Cafergot.Case Report
A 38 year old woman was admitted for acute left arm
ischaemia and bilateral intermittent calf claudication
at 20 m. The patient was in severe arm pain, her left
arm being cool and pale till over the elbow, with
concurrent loss of sensation and digital mobility. Pain
in the arm had started gradually 12 h before her
admission and worsened during the last 6 h. On
arrival, she was also complaining of chest pain
radiating to the left shoulder and a persisting
headache. She was a non smoker.
Physical examination revealed absent of brachial,
ulnar and radial arteries’ pulses in both upper limbs
and absent of femoral artery pulses on both sides.
With the hand held Doppler no audible flow signals
were present over the left brachial artery. The right
brachial artery pressure was 60 mmHg and both ankle
pressures were 70 mmHg.
The patient suffered from chronic migraine and
underwent treatment with ergotamine tartrateing author. E.A. Aslanidou, MD, Vascular Unit of the
l Department, G. Gennimatas Hospital, Aristotle
Thessaloniki, Ethnikis Aminis 41, 54635 Thessaloniki,
: aslanidoueleni@yahoo.gr
0149 + 03 q 2005 Published by Elsevier Ltd. Open access unsuppositories for more than 10 years. During the last
2 months, migraine deteriorated and she started drug
overdosing. She was currently taking 600–800 mg
ergotamine tartrate per day. At that same period she
experienced episodes of digital numbness and typical
intermittent calf claudication which she attributed to
sciatica.
The ECG on admission showed a sinus tachycardia
and no ischeamic disorders. An angiogram was
performed immediately which showed diffuse vasos-
pasms. In particular we found a smooth edged gradual
narrowing and obstruction of a seemingly left brachial
artery and threadlike flow to the right radial and ulnar
arteries and subocclusion of both superficial femoral
arteries (Figs. 1 and 2).
In combination to patient’s medical history, the
angiographic picture was attributed to ergotism and
the treatment started, including:
1 discontinuation of all ergot-alkaloid products
2 hydration with crystalloid i.v solutions
3 LMWH (enoxaparine)-100 IU/kg twice daily
4 250 mg nitroglycerine IV in 24 h, under cardiac
monitoring
5 IM opioid analgesiaEJVES Extra 10, 149–151 (2005)
doi:10.1016/j.ejvsextra.2005.08.012, available online at http://www.sciencedirect.com onder CC BY-NC-ND license. 
Fig. 1. Left and right arm angios-pre and after treatment.
G. N. Trellopoulos et al.150Within 24 h from treatment initiation, the right arm
responded to therapy followed some hours later by the
lower limbs, all showing a gradual clinical improvement
and increase in blood pressure up to 120 mmHg. The left
arm remained ischaemic with its brachial pressure at
80 mmHg. We preserved the same pharmacologicFig. 2. Legs’ angios-pre
EJVES Extra Vol 10, Month 2005scheme for the next 2 days and 48 h later palpable
pulses were restored all vessels, including the left arm.
By the end of third day ankle/brachial indices were
totally normalised. An angiogram a week later was
normal (Figs. 1 and 2). The patient was referred to the
neurologists for treatment of her migraine.and after treatment.
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Excessive use of ergot alkaloids can result in ergotism.
Compounds that can cause this condition include
ergotamine tartrate, dihydroergotamine and lysergic
acid diethylamide (LSD). It is rarely caused by
ingestion of foods contaminated with the fungus
Claviceps purpurea.1
Ergotamine is an a-adrenergic blocking agent.
It directly stimulates smooth muscles of peripheral
and cranial vessels and is also an agonist of
5-hydroxytryptamine (5-HT).
Ergot alkaloid agents exert their effect by direct
vasoconstriction, central sympatholysis, and periph-
eral-adrenergic blockade. They are metabolized in the
liver by a subgroup of the cytochrome P-450 iso-
enzymes CYP3A4.
Compounds also metabolized by this enzyme path-
way, including erythromycin, theophylline, carbamaza-
pine, and cyclosporine, can alter ergot metabolism,
resulting in increased drug levels. Protease inhibitors
such as ritonavir and indinivir, used for their antiviral
properties in patients positive for human immuno-
deficiency virus (HIV), are also metabolized through the
cytochrome P-450 pathway and are potent inhibitors of
the CYP3A4 isoenzyme. Therefore, the HIV-positive
population receiving antiviral therapy may be a group at
risk for ergotism through decreased hepatic metabolism
of ergot preparations.2,3
Cafergot, a widely prescribed drug for the treat-
ment of migraine consists of ergotamine tartrate and
caffeine. The latter is by itself a potent vasoconstrictor,
and it enhances the vascular effects of ergotamine.
The disorders of iatrogenic ergotism include gastro-
intestinal complaints, neurologic symptoms and vascu-
lar symptoms of the extremities. The vascular symptoms
appear in the form of ischaemia due to vasospasm to
either the upper extremities or most commonly the
lower extremities, bilaterally or unilaterally. Patients
with symptomatic vasospasm present with symptoms
of vascular insufficiency, most commonly in both lower
extremities. Patients complain of relatively recent onset
of numbness and intermittent claudication progressing
to rest pain with coolness and pallor and if the condition
is neither recognised nor treated properly, ischaemic
ulcers and frank gangrene may develop. In the 17th
century this presentation was called ‘Saint Anthony’s
fire’ to describe extremities with gangrene suffering
from burning pain. Victims of the disease prayed at Saint
Anthony’s shrine for relief.1 The gastrointestinal side
effects are the most common and include cramping,
abdominal pain, nausea, vomiting and diarrhea.In pregnant women, uterine cramping and abortions
can occur. Neurologic side effects consist of headaches,
vertigo, impaired mental function, symptoms of phy-
chosis, convulsions in the form of grand mal epilepsy
and coma.
Management of iatrogenic ergotism begins with
discontinuation of all agents containing ergotamine
tartrate. Other vasoconstrictors such as those contain-
ing caffeine (coffee, tea) or nicotine should also be
discontinued.
Ergot drug withdrawl—together with fluid therapy
and systemic heparinization—usually improves
patients’ symptoms.
However, additional aggressive therapy is required
in patients who have more severe ischaemic symp-
toms or whose limbs are threatened by gangrene.
† Prazocin hydrochloride, 1 mg orally three times per
day may be given.4 It is a direct acting vasodilator,
reducing peripheral vascular resistance through its
a-adrenergic blocking action.
† Nifedipine, given 20 mg orally twice daily has been
reported to improve the symptoms and eliminate
the vasospasm.
† Sodium Nitroprusside, a potent direct smooth
muscle vasodilator, is recommended. Its infusion
rate and duration should be titrated and monitored
carefully.5
† Nitroglycerine and prostaglandins have been used
successfully.
Ergotism has a sporadic nature and no specific
therapy. No single agent, or procedure has been
consistently successful, as evidenced by the large
number of therapeutic measures and drugs that have
been used.4,6References
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